Form D — Ardego Therapeutics, Inc.
0002138133-26-000001 · filed Jun 3, 2026
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $3,000,000
- Total sold
- $50,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Ardego Therapeutics, Inc.
- CIK
- 2138133
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2026
- Address
- 207A PERRY PARKWAY, SUITE 6
GAITHERSBURG, MD 20877 - Phone
- 402-980-9184
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
ETHAN EUGENE MANN · Executive OfficerGAITHERSBURG, MD Find on LinkedIn ↗
-
BEVERLY SUE PACKARD · Executive OfficerGAITHERSBURG, MD Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗